Sucralfate is an anti-ulcer medication used to treat acid-related stomach conditions, such as ulcers and gastroesophageal reflux disease (GERD). It is available in oral tablet and suspension forms, and is typically taken once or twice daily. While it is generally a safe and effective medication, there are some potential side effects that doctors should be aware of when prescribing it to their patients. In this article, we will discuss the hidden side effects of sucralfate and how to manage them.
The most common side effects of sucralfate include nausea, vomiting, diarrhea, constipation, headache, and dizziness. These side effects are usually mild and do not require medical attention unless they become severe or do not go away. It is important to note that these side effects are more likely to occur if the medication is taken on an empty stomach.
Less common side effects of sucralfate include stomach pain, gas, indigestion, and a metallic taste in the mouth. These side effects are usually mild and do not require medical attention unless they become severe or do not go away. It is important to note that these side effects are more likely to occur if the medication is taken on an empty stomach.
Rare side effects of sucralfate include rash, hives, itching, difficulty breathing, chest tightness, swelling of the face, lips, tongue, or throat, and hoarseness. If any of these side effects occur. It is important to note that these side effects are more likely to occur if the medication is taken on an empty stomach.
Sucralfate is a safe and effective medication for treating acid-related stomach conditions. However, it can cause side effects, including nausea, vomiting, diarrhea, constipation, headache, and dizziness. If you experience any of the rare side effects, such as rash, hives, itching, difficulty breathing, chest tightness, swelling of the face, lips, tongue, or throat, or hoarseness.
1.
Study Finds Microplastics Near Tumors; Experts Doubt Results
2.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
3.
Screening for prostate cancer: is it time to give up digital rectal examination?
4.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
5.
Neural networks and label-free microscopy enable accurate detection of pancreatic tumors
1.
Different Types of Blood Dyscrasias
2.
Understanding the Importance of Red Cell Distribution Width (RDW) in Blood Tests
3.
A Novel Gemcitabine-Releasing Intravesical System for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer
4.
Exploring the Potential of Bendamustine in Cancer Treatment
5.
Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
Oropharyngeal Cancer in Relation to HPV Status
4.
Navigating the Complexities of Ph Negative ALL - Part X
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation